CLINICAL_TRIALS
trial_result
· 2013-08-12
Clinical Trial Update: Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B
Summary
Post-marketing surveillance trial completed to observe safety and efficacy of BeneFIX in patients with Hemophilia B. Results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hemophilia B | Status: COMPLETED | Results posted: 2013-08-12